Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT01597258 · COMPLETED

Trial details

NCT number: NCT01597258
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2012-05-29
Primary completion: 2018-03-16
Enrollment: 2029

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.